Howard Fillit
Alzheimer's Drug Discovery Foundation(US)Acumen Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Health Systems, Economic Evaluations, Quality of Life, Cholinesterase and Neurodegenerative Diseases, Frailty in Older Adults
Most-Cited Works
- → A call for transparent reporting to optimize the predictive value of preclinical research(2012)1,197 cited
- → Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis(2016)1,157 cited
- → Predicting Alzheimer’s disease progression using multi-modal deep learning approach(2019)391 cited
- → The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease(2020)352 cited
- → Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders(1994)325 cited
- → Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis(2021)293 cited